Skip to content
★ Sign in to follow
BJ

Beit Jala Pharmaceutical Stock: price and insider trades · Palestine

1 insider bought shares over the last 90 days, the latest by حمد جمال اسعد مصري, filed 20 Sept 2026.

Insider Decl.
10
Thresholds
n/a
Buy Volume
n/a
5 ops. · all time
Sell Volume
n/a
5 ops. · all time

Beit Jala Pharmaceutical: what insiders have been doing

This page follows insider dealings at Beit Jala Pharmaceutical as filed with PCMA / Palestine Exchange. 4 insiders have disclosed 5 filings since 15 November 2025.

Open-market activity splits into 3 purchases and 2 sales; 2 insiders sit on the buying side and 2 insiders on the selling side. The totals exclude 5 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 2 board members.

The last insider purchase was made public on 20 September 2026, 58 days ago.

Across the 51 companies tracked on its exchange, the median is 9 filings; at 5 filings, this issuer sits below that mark. Our records for Beit Jala Pharmaceutical go back to 2021, with 5 purchases and 5 sales on the open market in total.

These figures are compiled from regulatory filings published by PCMA / Palestine Exchange. They describe what insiders did and are not a recommendation.

Who traded when

BuySale
حمد جمال اسعد مصري1 buy2 sales
شركة فلسطين للاستثمار الصناعي2 buys
Sukiyaki Holding 4 Limited1 sale
شركة النواه لادارة الاستثمارات1 sale
ليث عبدالحكيم حسن فقها1 buy

Financial data

· cache

Last declaration on 20 September 2026

T+90 is the date 90 days after the filing, the exit horizon used to measure each purchase.

Declarations10 total

10 of 10 declarations

About Beit Jala Pharmaceutical

Beit Jala Pharmaceutical is a pharmaceutical company based in Beit Jala, specializing in the manufacture of medicines and health products. It operates in the XPAE market.

Written on 14 November 2026 from the filings and market data available that day. Live figures are in the blocks above.

The weekly insider digest, free

One email on Fridays: the insider clusters and single-name signals worth reading. Unsubscribe in one click.